# Health-related quality of life in patients receiving medicinal cannabis: systematic review and meta-analysis of primary research findings 2015-2025.

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/medicinal-cannabis-quality-of-life-systematic-review-2025/
> **Published:** 2026-04-27T13:23:27-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:01:12-04:00
> **Clinical Summary:** New systematic review finds medicinal cannabis consistently improves health-related quality of life across chronic conditions in short and long-term studies.

---

CED Clinical Relevance  #100High Clinical Relevance
Evidence Brief | CED Clinic[Systematic review](https://cedclinic.com/cannabinoid-safety-efficacy-mental-health-study/) and meta-analysis finds medicinal cannabis associated with improved health-related [quality of life](https://cedclinic.com/cannabis-policy-enforcement-february-26-2026/) across chronic conditions, with effects sustained over 12 months.
[Quality Of Life](https://cedclinic.com/cannabis-policy-enforcement-february-26-2026/)Chronic ConditionsPatient OutcomesMeta-AnalysisMedicinal Cannabis

[Systematic review](https://cedclinic.com/cannabinoid-safety-efficacy-mental-health-study/) and meta-analysis finds medicinal cannabis associated with improved health-related quality of life across chronic conditions, with effects sustained over 12 months.

What This Study Teaches Us

This meta-analysis provides the most comprehensive synthesis to date of quality of life outcomes following medicinal cannabis treatment across diverse chronic conditions. The sustained improvements over 12 months suggest that patient-reported benefits may persist with continued treatment, addressing a key gap in long-term outcome data.

Why This Matters
Quality of life is often the primary concern for patients with chronic conditions, yet it’s frequently overlooked in [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) focused on symptom-specific outcomes. This evidence supports quality of life as a legitimate treatment target and provides a framework for measuring this important patient-centered outcome in [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/).

Study Snapshot

Study Type
Systematic Review and Meta-Analysis

Population
Patients with chronic health conditions receiving medicinal cannabis, multiple studies from 2015-2025

Intervention
Medicinal [cannabis therapy](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/)

Comparator
Pre-treatment baseline measures

Primary Outcome
Health-related quality of life using validated measures

Key Finding
Quality of life improvements observed across short-term, medium-term, and long-term follow-up periods

Journal
Quality of Life Research

Year
2025

Clinical Bottom Line
Medicinal cannabis appears consistently associated with quality of life improvements across multiple chronic conditions and timeframes. These findings support incorporating validated quality of life measures into clinical assessments and suggest that patient reports of feeling ‘better overall’ may reflect measurable improvements in functional well-being.

What This Paper Does Not Show
The analysis cannot establish causation due to the predominantly observational nature of included studies and lack of placebo controls in most research. Specific mechanisms underlying quality of life improvements, optimal dosing strategies, or which patient populations benefit most remain undefined.

Where This Paper Deserves Skepticism
Pre-post comparisons without controls are vulnerable to placebo effects, regression to the mean, and natural disease fluctuations. The heterogeneity of conditions, cannabis formulations, and quality of life measures across studies may limit the generalizability of pooled effect estimates.

Dr. Caplan's Take
This confirms what I observe clinically – patients often report feeling ‘better overall’ even when specific symptoms show modest improvement. Having systematic evidence for quality of life benefits helps justify treatment decisions when targeting functional well-being rather than just symptom reduction. However, I remain cautious about the mostly uncontrolled nature of this evidence.

What a Careful Reader Should Take Away

Medicinal cannabis consistently associates with quality of life improvements across chronic conditions, providing evidence-based support for patient-reported functional benefits. However, the predominantly observational evidence base requires cautious interpretation, and individual patient responses will vary significantly.

Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/)

Have thoughts on this? Share it:

[X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Health-related%20quality%20of%20life%20in%20patients%20receiving%20medicinal%20cannabis%3A%20systematic%20review%20and%20meta-...%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2Fmedicinal-cannabis-quality-of-life-systematic-review-2025%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fmedicinal-cannabis-quality-of-life-systematic-review-2025%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Health-related%20quality%20of%20life%20in%20patients%20receiving%20medicinal%20cannabis%3A%20systematic%20review%20and%20meta-...%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2Fmedicinal-cannabis-quality-of-life-systematic-review-2025%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/)

Table of Contents

- [FAQ](#FAQ)[Does medicinal cannabis improve quality of life in patients with chronic conditions?](#Does_medicinal_cannabis_improve_quality_of_life_in_patients_with_chronic_conditions)
- [How long do the quality of life benefits of medicinal cannabis last?](#How_long_do_the_quality_of_life_benefits_of_medicinal_cannabis_last)
- [What types of chronic conditions were studied in this research?](#What_types_of_chronic_conditions_were_studied_in_this_research)
- [How reliable is the evidence for medicinal cannabis improving quality of life?](#How_reliable_is_the_evidence_for_medicinal_cannabis_improving_quality_of_life)
- [When might patients expect to see quality of life improvements with medicinal cannabis?](#When_might_patients_expect_to_see_quality_of_life_improvements_with_medicinal_cannabis)
- [Related](#Related)

## FAQ

#### Does medicinal cannabis improve quality of life in patients with chronic conditions?

Yes, this systematic review and meta-analysis found that medicinal cannabis is associated with improved health-related quality of life across various chronic health conditions. The improvements were observed across short-term (2 weeks to 3 months), medium-term (3-12 months), and long-term (≥12 months) treatment periods.

#### How long do the quality of life benefits of medicinal cannabis last?

The quality of life improvements associated with medicinal cannabis appear to be sustained over extended periods. This study found evidence of benefits maintained for 12 months or longer, suggesting the therapeutic effects are not just temporary improvements.

#### What types of chronic conditions were studied in this research?

The systematic review included studies examining medicinal cannabis treatment across various chronic health conditions that impact quality of life. The researchers used validated health-related quality of life measures to assess outcomes across this diverse range of conditions.

#### How reliable is the evidence for medicinal cannabis improving quality of life?

The evidence comes from a comprehensive systematic review and meta-analysis covering studies from 2015-2025, which represents the highest level of evidence synthesis. The researchers assessed risk of bias in randomized controlled trials and used validated quality of life measurement tools to ensure reliable findings.

#### When might patients expect to see quality of life improvements with medicinal cannabis?

Quality of life improvements can be observed as early as 2 weeks to 3 months after starting medicinal cannabis treatment. The study categorized benefits into short-term (2 weeks-3 months), medium-term (3-12 months), and long-term (≥12 months) periods, with positive effects seen across all timeframes.

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).